Skip to main content
TipRanks
Go Ultimate75% OFF

Entheon Biomedical (1XU) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Entheon Biomedical has a market cap or net worth of EUR 440.55K. The enterprise value is EUR 1.06M.

Market Cap
EUR 440.55K
Enterprise Value
EUR 1.06M

Share Statistics

Entheon Biomedical has 13,858,926 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,858,926
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Entheon Biomedical’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -103.15%.

Return on Equity (ROE)
-1.00
Return on Assets (ROA)
-0.92
Return on Invested Capital (ROIC)
-103.15%
Return on Capital Employed (ROCE)
-1.03
Revenue Per Employee
0
Profits Per Employee
-324.01K
Employee Count
1
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Entheon Biomedical is -4.27. Entheon Biomedical’s PEG ratio is -0.08.

PE Ratio
-4.27
PS Ratio
0.00
PB Ratio
4.28
Price to FCF
-4.40
Price to Operating Cash Flow
-4.40
PEG Ratio
-0.08

Income Statement

In the last 12 months, Entheon Biomedical had revenue of 0 and earned -324.01K in profits. Earnings per share was -0.02.

Revenue
0
Gross Profit
0
Operating Income
-334.22K
Pretax Income
-324.01K
Net Income
-324.01K
EBITDA
-334.22K
Earnings Per Share (EPS)
-0.02

Cash Flow

In the last 12 months, operating cash flow was -314.66K and capital expenditures 0, giving a free cash flow of -314.66K billion.

Operating Cash Flow
-314.66K
Free Cash Flow
-314.66K
Free Cash Flow per Share
-0.02

Dividends & Yields

Entheon Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-22.70%
Earnings Yield
-23.42%

Stock Price Statistics

Beta
-0.78
52-Week Price Change
-36.17%
50-Day Moving Average
0.03
200-Day Moving Average
0.03
Relative Strength Index (RSI)
88.74
Average Volume (3m)
187

Important Dates

Entheon Biomedical upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 22, 2026
Next Earnings Date
Mar 30, 2027
Ex-Dividend Date
―

Financial Position

Entheon Biomedical as a current ratio of 11.72, with Debt / Equity ratio of 0.00%

Current Ratio
11.72
Quick Ratio
11.72
Debt to Market Cap
0.00
Net Debt to EBITDA
0.96
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Entheon Biomedical has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Entheon Biomedical EV to EBITDA ratio is -3.78, with an EV/FCF ratio of -3.38.

EV to Sales
0.00
EV to EBITDA
-3.78
EV to Free Cash Flow
-3.38
EV to Operating Cash Flow
-3.38

Balance Sheet

Entheon Biomedical has EUR 321.83K in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 321.83K billion.

Cash & Marketable Securities
EUR 321.83K
Total Debt
EUR 0.00
Net Cash
EUR 321.83K
Net Cash Per Share
EUR 0.02
Tangible Book Value Per Share
EUR 0.02

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%